Effects of Indomethacin on Viral Replication Markers in Asymptomatic Carriers of Hepatitis B: A Randomized, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of Indomethacin on Viral Replication Markers in Asymptomatic Carriers of Hepatitis B: A Randomized, Placebo-Controlled Trial

Published:2005-04 Issue:4 Volume:100 Page:856-861
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Bahrami Hossein,Daryani Nasser E.,Haghpanah Babak,Moayyeri Alireza,Moghadam Katayoon Fayaz,Mirmomen Shahram,Kamangar Farin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Hepatitis B: global importance and need for control

2. Chronic hepatitis B

3. Interferon signalling through arachidonic acid-dependent pathways: A clue to adjuvant therapy for chronic viral hepatitis? Hannigan GE, Williams BRG. Signal transduction by interferon-α through arachidonic metabolism. Science 1991;251:204–207

4. Signal Transduction by Interferon-α Through Arachidonic Acid Metabolism

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: effect on virus-induced COX-2 expression;Journal of Virus Eradication;2024-09

2. Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity;European Journal of Medicinal Chemistry;2024-03

3. Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response;iScience;2023-09

4. Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin;BioMed;2023-03-10

5. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents;The Lancet Infectious Diseases;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3